Department of Dermatology, Henry Ford Hospital, Detroit, Michigan.
Dermatology Associates PC, Tigard, Oregon.
J Am Acad Dermatol. 2017 May;76(5):958-972.e2. doi: 10.1016/j.jaad.2016.12.043. Epub 2017 Mar 1.
Since the publication of the last US national burden of skin disease report in 2006, there have been substantial changes in the practice of dermatology and the US health care system. These include the development of new treatment modalities, marked increases in the cost of medications, increasingly complex payer rules and regulations, and an aging of the US population. Recognizing the need for up-to-date data to inform researchers, policy makers, public stakeholders, and health care providers about the impact of skin disease on patients and US society, the American Academy of Dermatology produced a new national burden of skin disease report. Using 2013 claims data from private and governmental insurance providers, this report analyzed the prevalence, cost, and mortality attributable to 24 skin disease categories in the US population. In this first of 3 articles, the presented data demonstrate that nearly 85 million Americans were seen by a physician for at least 1 skin disease in 2013. This led to an estimated direct health care cost of $75 billion and an indirect lost opportunity cost of $11 billion. Further, mortality was noted in half of the 24 skin disease categories.
自 2006 年发布上一份美国国家皮肤病负担报告以来，皮肤病学实践和美国医疗保健系统发生了重大变化。这些变化包括新治疗方式的发展、药物成本的大幅增加、支付者规则和法规的日益复杂以及美国人口的老龄化。为了满足研究人员、政策制定者、公众利益相关者和医疗保健提供者了解皮肤病对患者和美国社会影响的最新数据需求，美国皮肤病学会发布了一份新的国家皮肤病负担报告。该报告使用来自私人和政府保险提供商的 2013 年理赔数据，分析了美国人口中 24 种皮肤病类别的患病率、成本和死亡率。在这三篇文章中的第一篇中，所呈现的数据表明，2013 年，近 8500 万美国人因至少 1 种皮肤病就诊于医生。这导致了估计 750 亿美元的直接医疗保健费用和 110 亿美元的间接错失机会成本。此外，在 24 种皮肤病类别中有一半出现了死亡。
